_id
691b188c3c536f8df2318c09
Ticker
POXEL.PA
Name
Poxel SA
Exchange
PA
Address
Immeuble Le Sunway, Lyon, France, 69007
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.poxelpharma.com
Description
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial dysfunction; and Sumitomo Pharma for development and commercialization of Imeglimin. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
Last Close
0.235
Volume
196635
Current Price
0.241
Change
0.0015
Last Updated
2025-12-31T16:01:49.642Z
Image
https://logo.clearbit.com/www.poxelpharma.com
Ipo Date
-
Market Cap
12483096
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
2183000
Cost Of Revenue
1877000
Gross Profit
306000
Operating Expenses
2778000
Operating Income
-2472000
Interest Expense
653000
Pretax Income
-3125000
Net Income
-2617000
Eps
-
Dividends Per Share
-
Shares Outstanding
53690737
Income Tax Expense
-508000
EBITDA
-2472000
Operating Margin
-113.23866239120477
Total Other Income Expense Net
-653000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2183000
Quarters > 0 > income Statement > cost Of Revenue
1877000
Quarters > 0 > income Statement > gross Profit
306000
Quarters > 0 > income Statement > operating Expenses
2778000
Quarters > 0 > income Statement > operating Income
-2472000
Quarters > 0 > income Statement > interest Expense
653000
Quarters > 0 > income Statement > pretax Income
-3125000
Quarters > 0 > income Statement > net Income
-2617000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-508000
Quarters > 0 > income Statement > EBITDA
-2472000
Quarters > 0 > income Statement > operating Margin
-113.23866239120477
Quarters > 0 > income Statement > total Other Income Expense Net
-653000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
5474000
Quarters > 1 > income Statement > cost Of Revenue
1832000
Quarters > 1 > income Statement > gross Profit
3642000
Quarters > 1 > income Statement > operating Expenses
3490000
Quarters > 1 > income Statement > operating Income
152000
Quarters > 1 > income Statement > interest Expense
10475000
Quarters > 1 > income Statement > pretax Income
-11102000
Quarters > 1 > income Statement > net Income
-11047000
Quarters > 1 > income Statement > eps
-0.21477900830425042
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
51434263
Quarters > 1 > income Statement > income Tax Expense
-55000
Quarters > 1 > income Statement > EBITDA
-598999
Quarters > 1 > income Statement > operating Margin
2.7767628790646692
Quarters > 1 > income Statement > total Other Income Expense Net
-11254000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3656000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
10503000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
14852000
Quarters > 1 > balance Sheet > property Plant Equipment
1000
Quarters > 1 > balance Sheet > total Assets
14929000
Quarters > 1 > balance Sheet > payables
2053000
Quarters > 1 > balance Sheet > short Term Debt
14828000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
73866000
Quarters > 1 > balance Sheet > equity
-58937000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-11047000
Quarters > 1 > cash Flow > depreciation
29000
Quarters > 1 > cash Flow > change In Working Capital
-7200000
Quarters > 1 > cash Flow > cash From Operations
-14745000
Quarters > 1 > cash Flow > capital Expenditures
14745000
Quarters > 1 > cash Flow > cash From Investing
28000
Quarters > 1 > cash Flow > cash From Financing
15558000
Quarters > 1 > cash Flow > net Change In Cash
844000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.21477900830425042
Quarters > 1 > ratios > PB
-0.21032046732952137
Quarters > 1 > ratios > ROE
18.743743319137383
Quarters > 1 > ratios > ROA
-73.99691874874405
Quarters > 1 > ratios > FCF
-29490000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-5.387285348922178
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1162000
Quarters > 2 > income Statement > cost Of Revenue
1146000
Quarters > 2 > income Statement > gross Profit
16000
Quarters > 2 > income Statement > operating Expenses
3830000
Quarters > 2 > income Statement > operating Income
-3814000
Quarters > 2 > income Statement > interest Expense
3541000
Quarters > 2 > income Statement > pretax Income
-7362000
Quarters > 2 > income Statement > net Income
-7258000
Quarters > 2 > income Statement > eps
-0.16876124295050363
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
43007505
Quarters > 2 > income Statement > income Tax Expense
-104000
Quarters > 2 > income Statement > EBITDA
-3724000
Quarters > 2 > income Statement > operating Margin
-328.22719449225474
Quarters > 2 > income Statement > total Other Income Expense Net
-3548000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
2812000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
829000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5452000
Quarters > 2 > balance Sheet > property Plant Equipment
22000
Quarters > 2 > balance Sheet > total Assets
5588000
Quarters > 2 > balance Sheet > payables
2313000
Quarters > 2 > balance Sheet > short Term Debt
12377000
Quarters > 2 > balance Sheet > long Term Debt
35271000
Quarters > 2 > balance Sheet > total Liabilities
56160000
Quarters > 2 > balance Sheet > equity
-50572000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-7258000
Quarters > 2 > cash Flow > depreciation
96000
Quarters > 2 > cash Flow > change In Working Capital
1011000
Quarters > 2 > cash Flow > cash From Operations
-2860000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
64000
Quarters > 2 > cash Flow > cash From Financing
3267000
Quarters > 2 > cash Flow > net Change In Cash
471000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.16876124295050363
Quarters > 2 > ratios > PB
-0.20495152861267105
Quarters > 2 > ratios > ROE
14.351815233726173
Quarters > 2 > ratios > ROA
-129.88546886184682
Quarters > 2 > ratios > FCF
-2860000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.4612736660929433
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1026000
Quarters > 3 > income Statement > cost Of Revenue
1025000
Quarters > 3 > income Statement > gross Profit
1000
Quarters > 3 > income Statement > operating Expenses
5701000
Quarters > 3 > income Statement > operating Income
-5700000
Quarters > 3 > income Statement > interest Expense
3037000
Quarters > 3 > income Statement > pretax Income
-9055000
Quarters > 3 > income Statement > net Income
-8847000
Quarters > 3 > income Statement > eps
-0.2787604132233202
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31736931
Quarters > 3 > income Statement > income Tax Expense
2000
Quarters > 3 > income Statement > EBITDA
-5737000
Quarters > 3 > income Statement > operating Margin
-555.5555555555555
Quarters > 3 > income Statement > total Other Income Expense Net
-3355000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
2341000
Quarters > 3 > balance Sheet > short Term Investments
-86000
Quarters > 3 > balance Sheet > receivables
1564000
Quarters > 3 > balance Sheet > inventories
-1564000
Quarters > 3 > balance Sheet > total Current Assets
4520000
Quarters > 3 > balance Sheet > property Plant Equipment
120000
Quarters > 3 > balance Sheet > total Assets
4823000
Quarters > 3 > balance Sheet > payables
1212000
Quarters > 3 > balance Sheet > short Term Debt
6889000
Quarters > 3 > balance Sheet > long Term Debt
40143000
Quarters > 3 > balance Sheet > total Liabilities
53901000
Quarters > 3 > balance Sheet > equity
-49105000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-8847000
Quarters > 3 > cash Flow > depreciation
282000
Quarters > 3 > cash Flow > change In Working Capital
-546000
Quarters > 3 > cash Flow > cash From Operations
-7811000
Quarters > 3 > cash Flow > capital Expenditures
7811000
Quarters > 3 > cash Flow > cash From Investing
32000
Quarters > 3 > cash Flow > cash From Financing
2525000
Quarters > 3 > cash Flow > net Change In Cash
-5256000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.2787604132233202
Quarters > 3 > ratios > PB
-0.15576011345076876
Quarters > 3 > ratios > ROE
18.01649526524794
Quarters > 3 > ratios > ROA
-183.43354758449098
Quarters > 3 > ratios > FCF
-15622000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-15.226120857699804
Quarters > 3 > health Score
29
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6636000
Annuals > 0 > income Statement > cost Of Revenue
2978000
Annuals > 0 > income Statement > gross Profit
3658000
Annuals > 0 > income Statement > operating Expenses
7320000
Annuals > 0 > income Statement > operating Income
-3662000
Annuals > 0 > income Statement > interest Expense
14016000
Annuals > 0 > income Statement > pretax Income
-18464000
Annuals > 0 > income Statement > net Income
-18305000
Annuals > 0 > income Statement > eps
-0.38354025020778854
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
47726412
Annuals > 0 > income Statement > income Tax Expense
-159000
Annuals > 0 > income Statement > EBITDA
-4323000
Annuals > 0 > income Statement > operating Margin
-55.183845690174806
Annuals > 0 > income Statement > total Other Income Expense Net
-14802000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
3656000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10503000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
14852000
Annuals > 0 > balance Sheet > property Plant Equipment
1000
Annuals > 0 > balance Sheet > total Assets
14929000
Annuals > 0 > balance Sheet > payables
441000
Annuals > 0 > balance Sheet > short Term Debt
14828000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
73866000
Annuals > 0 > balance Sheet > equity
-58937000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-18305000
Annuals > 0 > cash Flow > depreciation
125000
Annuals > 0 > cash Flow > change In Working Capital
-6189000
Annuals > 0 > cash Flow > cash From Operations
-17605000
Annuals > 0 > cash Flow > capital Expenditures
17605000
Annuals > 0 > cash Flow > cash From Investing
92000
Annuals > 0 > cash Flow > cash From Financing
18825000
Annuals > 0 > cash Flow > net Change In Cash
1315000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.38354025020778854
Annuals > 0 > ratios > PB
-0.18949014045506218
Annuals > 0 > ratios > ROE
31.05858798377929
Annuals > 0 > ratios > ROA
-122.61370486971666
Annuals > 0 > ratios > FCF
-35210000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-5.305907172995781
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1981000
Annuals > 1 > income Statement > cost Of Revenue
1980000
Annuals > 1 > income Statement > gross Profit
1000
Annuals > 1 > income Statement > operating Expenses
28765000
Annuals > 1 > income Statement > operating Income
-28764000
Annuals > 1 > income Statement > interest Expense
6148000
Annuals > 1 > income Statement > pretax Income
-35088000
Annuals > 1 > income Statement > net Income
-35090000
Annuals > 1 > income Statement > eps
-0.9090058700951601
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
38602611
Annuals > 1 > income Statement > income Tax Expense
2000
Annuals > 1 > income Statement > EBITDA
-12173000
Annuals > 1 > income Statement > operating Margin
-1451.9939424533063
Annuals > 1 > income Statement > total Other Income Expense Net
-6324000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2341000
Annuals > 1 > balance Sheet > short Term Investments
-86000
Annuals > 1 > balance Sheet > receivables
509000
Annuals > 1 > balance Sheet > inventories
-1564000
Annuals > 1 > balance Sheet > total Current Assets
4520000
Annuals > 1 > balance Sheet > property Plant Equipment
120000
Annuals > 1 > balance Sheet > total Assets
4823000
Annuals > 1 > balance Sheet > payables
1212000
Annuals > 1 > balance Sheet > short Term Debt
6889000
Annuals > 1 > balance Sheet > long Term Debt
40143000
Annuals > 1 > balance Sheet > total Liabilities
53901000
Annuals > 1 > balance Sheet > equity
-49105000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-35090000
Annuals > 1 > cash Flow > depreciation
17319000
Annuals > 1 > cash Flow > change In Working Capital
-1286000
Annuals > 1 > cash Flow > cash From Operations
-13978000
Annuals > 1 > cash Flow > capital Expenditures
17025000
Annuals > 1 > cash Flow > cash From Investing
41000
Annuals > 1 > cash Flow > cash From Financing
3230000
Annuals > 1 > cash Flow > net Change In Cash
-10717000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.9090058700951601
Annuals > 1 > ratios > PB
-0.18395297778230324
Annuals > 1 > ratios > ROE
71.45911821606761
Annuals > 1 > ratios > ROA
-727.55546340452
Annuals > 1 > ratios > FCF
-31003000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-15.650176678445229
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
674000
Annuals > 2 > income Statement > cost Of Revenue
672000
Annuals > 2 > income Statement > gross Profit
2000
Annuals > 2 > income Statement > operating Expenses
21892000
Annuals > 2 > income Statement > operating Income
-21890000
Annuals > 2 > income Statement > interest Expense
4309000
Annuals > 2 > income Statement > pretax Income
-31396000
Annuals > 2 > income Statement > net Income
-31398000
Annuals > 2 > income Statement > eps
-1.0798330870652655
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
29076716
Annuals > 2 > income Statement > income Tax Expense
2000
Annuals > 2 > income Statement > EBITDA
-28023000
Annuals > 2 > income Statement > operating Margin
-3247.7744807121658
Annuals > 2 > income Statement > total Other Income Expense Net
-9506000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
13058000
Annuals > 2 > balance Sheet > short Term Investments
-193000
Annuals > 2 > balance Sheet > receivables
1062000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
16574000
Annuals > 2 > balance Sheet > property Plant Equipment
1323000
Annuals > 2 > balance Sheet > total Assets
34714000
Annuals > 2 > balance Sheet > payables
2938000
Annuals > 2 > balance Sheet > short Term Debt
18221000
Annuals > 2 > balance Sheet > long Term Debt
24515000
Annuals > 2 > balance Sheet > total Liabilities
52955000
Annuals > 2 > balance Sheet > equity
-18241000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-31398000
Annuals > 2 > cash Flow > depreciation
555000
Annuals > 2 > cash Flow > change In Working Capital
-3336000
Annuals > 2 > cash Flow > cash From Operations
-21813000
Annuals > 2 > cash Flow > capital Expenditures
23000
Annuals > 2 > cash Flow > cash From Investing
-5000
Annuals > 2 > cash Flow > cash From Financing
2585000
Annuals > 2 > cash Flow > net Change In Cash
-19229000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.0798330870652655
Annuals > 2 > ratios > PB
-0.3730032094731649
Annuals > 2 > ratios > ROE
172.12872101310234
Annuals > 2 > ratios > ROA
-90.44765800541569
Annuals > 2 > ratios > FCF
-21836000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-32.397626112759646
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
13397000
Annuals > 3 > income Statement > cost Of Revenue
59000
Annuals > 3 > income Statement > gross Profit
13338000
Annuals > 3 > income Statement > operating Expenses
35801000
Annuals > 3 > income Statement > operating Income
-22462000
Annuals > 3 > income Statement > interest Expense
2950000
Annuals > 3 > income Statement > pretax Income
-23760000
Annuals > 3 > income Statement > net Income
-23762000
Annuals > 3 > income Statement > eps
-0.8296111622746946
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28642334
Annuals > 3 > income Statement > income Tax Expense
2000
Annuals > 3 > income Statement > EBITDA
-22524000
Annuals > 3 > income Statement > operating Margin
-167.66440247816675
Annuals > 3 > income Statement > total Other Income Expense Net
-1298000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
32287000
Annuals > 3 > balance Sheet > short Term Investments
3533000
Annuals > 3 > balance Sheet > receivables
2625000
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
36337000
Annuals > 3 > balance Sheet > property Plant Equipment
1716000
Annuals > 3 > balance Sheet > total Assets
54889000
Annuals > 3 > balance Sheet > payables
3671000
Annuals > 3 > balance Sheet > short Term Debt
5046000
Annuals > 3 > balance Sheet > long Term Debt
29002000
Annuals > 3 > balance Sheet > total Liabilities
46683000
Annuals > 3 > balance Sheet > equity
8206000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-23763000
Annuals > 3 > cash Flow > depreciation
556000
Annuals > 3 > cash Flow > change In Working Capital
1898000
Annuals > 3 > cash Flow > cash From Operations
-16893000
Annuals > 3 > cash Flow > capital Expenditures
49000
Annuals > 3 > cash Flow > cash From Investing
-42000
Annuals > 3 > cash Flow > cash From Financing
9025000
Annuals > 3 > cash Flow > net Change In Cash
-7916000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.8296111622746946
Annuals > 3 > ratios > PB
0.8167567823543749
Annuals > 3 > ratios > ROE
-289.56860833536433
Annuals > 3 > ratios > ROA
-43.291005483794564
Annuals > 3 > ratios > FCF
-16942000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.2646114801821304
Annuals > 3 > health Score
15
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > Net Margin
-1.1988089784699953
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.785604900459418
Risk > final Score
15
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
37
Prev Profitabilities > 1
29
Prev Profitabilities > 2
36
Prev Risks > 0
30
Prev Risks > 1
26
Prev Risks > 2
22
Prev Liquidities > 0
54
Prev Liquidities > 1
29
Prev Liquidities > 2
48
Updated At
2026-01-20T23:10:20.460Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-23
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-22
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.17
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.17
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-10-03
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.43
Earnings History > 3 > eps Difference
0.26
Earnings History > 3 > surprise Percent
60.4651
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-05-16
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2024-02-15
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.43
Earnings History > 5 > eps Difference
0.43
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-08
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-30
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.42
Earnings History > 7 > eps Estimate
-0.42
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-03
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-0.23
Earnings History > 8 > eps Difference
0.23
Earnings History > 8 > surprise Percent
100
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-23
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.62
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
-0.42
Earnings History > 9 > surprise Percent
-210
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-10-04
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-08
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.46
Earnings History > 11 > eps Estimate
-0.61
Earnings History > 11 > eps Difference
0.15
Earnings History > 11 > surprise Percent
24.5902
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-05-17
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-03-23
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.55
Earnings History > 13 > eps Estimate
-0.98
Earnings History > 13 > eps Difference
0.43
Earnings History > 13 > surprise Percent
43.8776
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-10-20
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-07-21
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.28
Earnings History > 15 > eps Estimate
-0.21
Earnings History > 15 > eps Difference
-0.07
Earnings History > 15 > surprise Percent
-33.3333
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-04-21
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2021-03-24
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.69
Earnings History > 17 > eps Estimate
-0.77
Earnings History > 17 > eps Difference
0.08
Earnings History > 17 > surprise Percent
10.3896
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-10-20
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-07-21
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.45
Earnings History > 19 > eps Estimate
-0.66
Earnings History > 19 > eps Difference
0.21
Earnings History > 19 > surprise Percent
31.8182
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-05-25
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-26
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.77
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.77
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-10-07
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-07-15
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.22
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.22
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-04-08
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-12-31
Earnings History > 25 > report Date
2019-03-22
Earnings History > 25 > date
2018-12-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
0.23
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.23
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-09-30
Earnings History > 26 > report Date
2018-10-16
Earnings History > 26 > date
2018-09-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-06-30
Earnings History > 27 > report Date
2018-09-19
Earnings History > 27 > date
2018-06-30
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
0.3
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-03-31
Earnings History > 28 > report Date
2018-04-23
Earnings History > 28 > date
2018-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
0
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-12-31
Earnings History > 29 > report Date
2018-03-23
Earnings History > 29 > date
2017-12-31
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.55
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-06-30
Earnings History > 30 > report Date
2017-08-24
Earnings History > 30 > date
2017-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
-0.42
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial dysfunction; and Sumitomo Pharma for development and commercialization of Imeglimin. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APOXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar - Yahoo Finance
11/24/2025
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar Yahoo Finance
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Poxel SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.